Open AccessSilencing homeobox C6 inhibits colorectal cancer cell proliferation
Author(s) -
Meiling Ji,
Qi Sheng Feng,
Guodong He,
Yang Liu,
Wentao Tang,
Xinyuan Lao,
Dexiang Zhu,
Lin Qi,
Pingping Xu,
Wei Ye,
Jianmin Xu
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.8703
Subject(s) - homeobox , cancer research , gene silencing , colorectal cancer , carcinogenesis , cell growth , homeobox a1 , biology , transcription factor , downregulation and upregulation , small hairpin rna , cancer , cell culture , gene knockdown , gene , genetics
Homeobox C6 (HOXC6), a member of the homeobox family that encodes highly conserved transcription factors, plays a vital role in various carcinomas. In this study, we used a tissue microarray (TMA) consisting of 462 CRC samples to demonstrate that HOXC6 is more abundantly expressed in colorectal cancer (CRC) tissues than adjacent normal mucosa. Clinicopathological data indicated that higher HOXC6 expression correlated with poor overall survival and was associated with primary tumor location in the right colon, primary tumor (pT) stage 3/4 and primary node (pN) stage 1/2. Multivariate analysis showed that high HOXC6 expression was an independent risk factor for poor CRC patient prognosis. HOXC6 downregulation via lentivirus-mediated expression of HOXC6-targeting shRNA reduced HCT116 cell viability and colony formation in vitro, and reduced growth of subcutaneous xenografts in nude mouse. HOXC6 thus appears to promote CRC cell proliferation and tumorigenesis through autophagy inhibition and mTOR pathway activation.